← Home
Kyowa Kirin
-11.97%
Pharma / Pharma
📢 Press Releases
| Date | Press release |
|---|---|
| 2025-12-11 02:30:00 | Kyowa Kirin Announces Proposed Appointment Of Abdul Mullick To President And Chief Executive Officer, While Former Ceo Masashi Miyamoto To Remain Chairman Tokyo--(business wire)--kyowa kirin co., ltd. (tse:4151, kyowa kirin), a japan-based global specialty pharmaceutical company, today announced the board of directors’ decision to appoint abdul mullick, ph.d., currently president and chief operating officer (coo), to the role of president and chief executive officer (ceo). the appointment will become effective march 2026 following the conclusion of the ordinary general meeting of shareholders. as mullick takes on the role of president and ceo for. |
| 2025-11-18 09:07:00 | Kyowa Kirin To Present New Research Highlighting Mogamulizumab’s Clinical Utility And Strategic Potential In T-cell Lymphomas At 2025 Ash Annual Meeting Princeton, nj, nov. 18, 2025 (globe newswire) -- kyowa kirin, inc., a wholly owned subsidiary of kyowa kirin co. ltd (tse: 4151), today announced new clinical study data spotlighting the potential for mogamulizumab in the treatment of relapsed or refractory mycosis fungoides and sÉzary syndrome, and other mature t-cell lymphomas, will be featured in three poster presentations at the american society of hematology (ash) 2025 annual meeting in orlando, fl. the presentations will include new findings on mogamulizumab’s therapeutic benefit, safety, and pharmacodynamic profile, and insight into alternative dosing strategies, real-world treatment patterns, and relevant biomarker-associated outcomes that may serve as early indicators for treatment response. |
| 2025-11-03 03:00:00 | Kyowa Kirin International Announces Appointment Of Julie Dehaene-puype As President For The Region Galashiels, scotland & marlow, england--(business wire)--kyowa kirin international (“kki”), a group company of kyowa kirin co., ltd. (tse:4151, “kyowa kirin”), a japan-based global specialty pharmaceutical company, today announced the appointment of julie dehaene-puype as president for the region, effective 1 november 2025. julie follows the tenure of jeremy morgan, who has served as president for the international region since 2023. morgan will serve in an advisor role to the business through. |
| 2025-10-30 02:40:00 | Boehringer Ingelheim Acquires License From Kyowa Kirin Aimed At Developing A Novel Treatment For Patients With Autoimmune Diseases The licensed small molecule program aims to address significant unmet needs for autoimmune diseases . program adds to boehringer’s pipeline and its commitment to deliver breakthrough therapies for patients with inflammatory diseases. |
| 2025-08-19 09:01:00 | Kyowa Kirin Premiers New Ctcl Staging Tool For Healthcare Providers First-of-its kind tool to guide hcps on what to consider when staging patients with mycosis fungoides and sÉzary syndrome first-of-its kind tool to guide hcps on what to consider when staging patients with mycosis fungoides and sÉzary syndrome |
| 2025-07-29 08:00:00 |
|
| 2025-04-03 19:14:00 |
|
| 2025-02-26 08:00:00 |
|
| 2025-01-30 05:05:00 |
|
| 2025-01-28 10:00:00 |
|
| 2024-12-09 20:00:00 |
|
| 2024-10-31 02:40:00 |
|
| 2024-10-08 03:05:00 |
|
| 2024-09-19 08:00:00 |
|
| 2024-08-23 11:05:00 |
|
📰 Browse additional press releases for Kyowa Kirin!
Sign up for free or log in⚡ Instantly access "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free!